Laurion Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Laurion Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-52,943	Closed	-$2.79M	–	1667
2018 Q1	$2.79M	Buy	+52,943	New	+$3.09M	0.02%	539
2017 Q3	–	Sell	-50,232	Closed	-$4.7M	–	1967
2017 Q2	$4.7M	Buy	+50,232	New	+$3.07M	0.03%	528
2014 Q4	–	Sell	-5,900	Closed	-$268K	–	456
2014 Q3	$268K	Buy	+5,900	New	+$246K	0.01%	238
2014 Q1	–	Sell	-65,892	Closed	-$3.97M	–	326
2013 Q4	$3.97M	Buy	+65,892	New	+$3.58M	0.14%	81

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Laurion Capital Management's CLVS Position: Q2 2018 in Review

Laurion Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 52,943 shares — an estimated $2.79M sold.

Laurion Capital Management first reported a position in CLVS in Q4 2013 and held it in 4 quarters. The position peaked at $4.7M in Q2 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

Laurion Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
Laurion Capital Management sold 52,943 Clovis Oncology, Inc. shares in Q2 2018, an estimated $2.79M.
Laurion Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 4 quarters.
Laurion Capital Management's Clovis Oncology, Inc. position peaked at $4.7M in Q2 2017.
210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Laurion Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.